Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT06406075 Enrolling by invitation - Healthy Clinical Trials

Non-invasive Measurement of Glucose With Advanced Spectroscopy Techniques and Machine Learning Models

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

Primary aim of this pilot study is to provide evidence for a non-invasive, continuous, and transcutaneous measurement method to determine blood glucose levels robustly and accurately.

NCT ID: NCT06393634 Enrolling by invitation - Healthy Clinical Trials

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

T esters
Start date: May 8, 2024
Phase: Early Phase 1
Study type: Interventional

Testosterone abuse is extremely prevalent in athletes globally and especially in the United States professional sporting leagues

NCT ID: NCT06360874 Enrolling by invitation - Healthy Clinical Trials

A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults

Start date: May 9, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate Safety, Tolerability and Pharmacokinetic of ND-003 tablets in Healthy Adults

NCT ID: NCT06347627 Enrolling by invitation - Healthy Clinical Trials

Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18

Start date: December 22, 2023
Phase: N/A
Study type: Interventional

This study aims to comprehensively assess confidence in and acceptance of human papillomavirus (HPV) vaccines among Japanese parents and caregivers with daughters aged 12-18 and their decision-making process.

NCT ID: NCT06343636 Enrolling by invitation - Healthy Clinical Trials

A Phase 1 Study of VG-3927 in Healthy Adults

Start date: September 27, 2023
Phase: Phase 1
Study type: Interventional

A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VG-3927 in Healthy Adults

NCT ID: NCT06341634 Enrolling by invitation - Healthy Clinical Trials

Surveillance of Suicide Ideation in Adolescents (VISIA)

VISIA
Start date: February 6, 2024
Phase:
Study type: Observational

The goal of this observational study is to validate an AI algorithm's capability to differentiate the population with suicidal ideation from a control population using various multimodal variables, including voice analysis, facial emotions, natural language, and proteomics data. The primary research question it aims to answer is: Is it possible to identify suicidal ideation and suicide risk in adolescents early and non-intrusively using multimodal data analysis through digital instruments equipped with artificial intelligence? Participants in this study will be asked to: Complete psychometric instruments to establish a gold standard for detecting suicide risk and suicidal ideation. Provide voice recordings, facial emotion data, and linguistic content in natural and specific contexts. Participate in salivary proteomics data collection. This study compares three distinct groups: Ideation: Adolescent patients with current suicidal ideation. Clinical Population: Psychological or psychiatric patients of the same age and gender without suicidal ideation. General Population: Adolescents without known psychological or psychiatric pathology of the same age and gender, without suicidal ideation. Researchers will compare these groups to determine if the AI algorithm is effective in differentiating individuals with suicidal ideation (Group 1) from both a clinical control group (Group 2) and a general population control group (Group 3) using the collected multimodal data. The study aims to assess the algorithm's ability to identify early signs of suicide risk in these distinct participant populations.

NCT ID: NCT06332638 Enrolling by invitation - Healthy Clinical Trials

PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

Start date: March 19, 2024
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to explore pharmacokinetics, pharmacodynamics, and safety of tegoprazan 12.5 mg in healthy subjects when orally administered as a single dose or as multiple doses twice daily.

NCT ID: NCT06285630 Enrolling by invitation - Healthy Clinical Trials

The Development and Health of the Intestinal Flora During the First Year of Life

PREVENT
Start date: February 26, 2024
Phase:
Study type: Observational

In this research study (PREVENT 1), Alba Health, in collaboration with academic institutions (Uppsala University, COPSAC and University of Antwerp) is investigating the association between the developing gut microbiota (collection of microbes present in the human gut) in the first year of life and lifestyle, wellbeing and health in a Swedish population. The study is the first of its kind in a Swedish population to collect and associate microbiome composition to an extensive family history and health questionnaire, stool colour and crying type, building on learnings from previous studies performed in other countries, such as the HELMI and COPSAC studies (HELMI - Finnish Health and Early Life Microbiota cohort from the University of Helsinki in Finland; COPSAC - Copenhagen Prospective Studies on Asthma in Childhood in Denmark). The PREVENT 1 study is an observational research study led by Alba Health involving 300 families in Sweden with children between 0 and 12 months of age at the time of the study's start. After providing informed consent, the participating families will be asked to provide three stool samples from their child (the sample collection is not invasive and does not cause discomfort) and will be asked to answer questionnaires on lifestyle, well-being and family health. The participating families will not be asked to change their lifestyle beyond sample and data collection. From the collected stool samples, we will extract microbial DNA and subject this to deep metagenomic sequence analysis. The study will only analyze microbial DNA, any human related material will be discarded. The stool samples will be destroyed within one month of sequencing (maximum 3 months from collection). The data will be stored according to GDPR and Swedish law, with informed consent in Sweden and with appropriate security measures. All research will be carried out in Sweden.

NCT ID: NCT06229457 Enrolling by invitation - Healthy Clinical Trials

Development and Testing of a Sports Intervention to Promote Physical Activity in Rural Girls

GirlsPLAY
Start date: May 28, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to examine the impact of a 12-week sports sampling and physical literacy program on rural girls' physical activity.

NCT ID: NCT06119412 Enrolling by invitation - Healthy Clinical Trials

An Alternative Technique for Measuring Blood Pressure

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

This cross design study will be conducted to evaluate the combination of palpation and auscultation techniques as an alternative technique for the measurement of blood pressure. The main questions it aims to answer are: - Is there a statistical difference between the results of systolic blood pressure measured with the old and new technique? - Is there a statistical difference between the results of systolic blood pressure measured with the old and new technique? Participants' blood pressure will be measured twice.